HK1121670A1 - Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use - Google Patents
Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic useInfo
- Publication number
- HK1121670A1 HK1121670A1 HK08110565.6A HK08110565A HK1121670A1 HK 1121670 A1 HK1121670 A1 HK 1121670A1 HK 08110565 A HK08110565 A HK 08110565A HK 1121670 A1 HK1121670 A1 HK 1121670A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- composition
- inter
- preparation
- therapeutic use
- human plasma
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to an inner-alpha inhibitor protein (I alpha Ip). The invention also relates to a method for purifying the I alpha Ip composition and the usage for treating the human diseases such as pyaemia, septicemic shock, atrophic arthritis, cancer and infectious disease.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/036848 WO2005046587A2 (en) | 2003-11-08 | 2004-11-05 | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1121670A1 true HK1121670A1 (en) | 2009-04-30 |
Family
ID=39307922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08110565.6A HK1121670A1 (en) | 2004-11-05 | 2008-09-23 | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101160133B (en) |
HK (1) | HK1121670A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7932365B2 (en) | 2003-11-08 | 2011-04-26 | Pro Thera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
ES2673005T3 (en) * | 2008-05-28 | 2018-06-19 | Prothera Biologics, Inc | Preparation and composition of inter-alpha inhibitory proteins from blood |
US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
FR2946348B1 (en) * | 2009-06-05 | 2011-08-05 | Lab Francais Du Fractionnement | PROCESS FOR PREPARING A HIGH-DEPTH PURITY PROTHROMBIC COMPLEX COMPOSITION |
SG187599A1 (en) * | 2010-07-23 | 2013-03-28 | Baxter Int | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
US9572872B2 (en) | 2012-09-09 | 2017-02-21 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
CN112316148A (en) * | 2019-08-01 | 2021-02-05 | 成都夸常奥普医疗科技有限公司 | Use of a semi-fluid comprising plasma, pharmaceutical compositions comprising the semi-fluid and an active ingredient and process for preparing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1326893A2 (en) * | 2000-10-13 | 2003-07-16 | Octapharma AG | Plasma fraction containing bikunin, method for the production thereof and use of the same |
-
2004
- 2004-11-05 CN CN200480040150XA patent/CN101160133B/en active Active
-
2008
- 2008-09-23 HK HK08110565.6A patent/HK1121670A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101160133A (en) | 2008-04-09 |
CN101160133B (en) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002360592A8 (en) | Inhibitors of hepatitis c virus | |
NO20055863L (en) | W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors | |
AU2003299519A8 (en) | Hepatitis c virus inhibitors | |
PL373398A1 (en) | Heterocyclicsulfonamide hepatitis c virus inhibitors | |
HK1121670A1 (en) | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use | |
EP1408986A4 (en) | Proteomimetic compounds and methods | |
ATE451376T1 (en) | COMPOSITIONS SUITABLE AS INHIBITORS OF PROTEIN KINASES | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
NO20063193L (en) | Fused pyrrolocarbazoles and processes for their preparation | |
IL196815A0 (en) | Hepatitis c virus inhibitors | |
TW200508214A (en) | Novel compounds | |
MY140710A (en) | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus | |
ATE473980T1 (en) | TRIAZOLOPYRIDAZINE AS PROTEIN KINASE INHIBITORS | |
CY1108146T1 (en) | Beta-Amino-Heterocyclic-Dipeptidyl Peptide Suspensions for the Treatment or Prevention of Diabetes | |
WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
IL162828A0 (en) | Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection | |
NO20063196L (en) | New fused pyrrolocarbazoles | |
MA27880A1 (en) | TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | |
MXPA05009885A (en) | Novel fused triazolones and the uses thereof. | |
UA87494C2 (en) | Azaindoles useful as inhibitors of jak and other protein kinases | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
WO2005046587A3 (en) | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use | |
EP1802297A4 (en) | Compositions and methods for treatment of disease caused by yersinia spp infection | |
MXPA06000460A (en) | IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES. |